Stereospecific plasma binding of gliflumide, a new antidiabetic drug.
D000818:Animals; D044482:Benzeneacetamides; D001798:Blood Proteins / Q000378:metabolism*; D002417:Cattle; D007004:Hypoglycemic Agents / Q000097:blood*; D007328:Insulin / Q000097:blood; D007700:Kinetics; D011485:Protein Binding; D011743:Pyrimidines / Q000097:blood*; D013237:Stereoisomerism; D013449:Sulfonamides / Q000097:blood*; D013453:Sulfonylurea Compounds / Q000097:blood
D044482:Benzeneacetamides; D001798:Blood Proteins; D007004:Hypoglycemic Agents; D007328:Insulin; D011743:Pyrimidines; D013449:Sulfonamides; D013453:Sulfonylurea Compounds; C010968:gliflumide